GSK Pharma holds firm at higher levels after Q1 earnings

The result was announced during trading hours today, 7 May 2013.

Meanwhile, the BSE Sensex was up 171.85 points, or 0.87%, to 19,845.49.

On BSE, 17,949 shares were traded in the counter as against an average daily volume of 7,930 shares in the past one quarter.

The stock hit a high of Rs 2,522 so far during the day, which is also a record high for the counter. The stock hit a low of Rs 2,310.25 so far during the day. The stock had hit a 52-week low of Rs 1,916 on 4 July 2012.

The stock had underperformed the market over the past one month till 6 May 2013, rising 5.59% compared with the Sensex's 6.63% rise. The scrip had, however, outperformed the market in past one quarter, rising 12.41% as against Sensex's 0.17% rise.

The large-cap company has an equity capital of Rs 84.70 crore. Face value per share is Rs 10.

GlaxoSmithKline Pharmaceuticals (GSK Pharma) profit before operations before other income and exceptional items fell 17.19% to Rs 163.45 crore in Q1 March 2013 over Q1 March 2012. Total income from operations (net) rose 1.33% to Rs 636.88 crore in Q1 March 2013 over Q1 March 2012.

The company said the growth for the quarter was impacted by the core pharmaceuticals business, which was flat, compared to the same period last year. There was a significant impact on growth due to supply chain related issue, the company said in a statement.

GSK Pharma is engaged in manufacturing and marketing pharmaceutical and healthcare products such as betamethasone, cefuroxime and ranitidine.

Powered by Capital Market - Live News